Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Role of two nutritional hepatic markers (insulin‐like growth factor 1 and transthyretin) in the clinical assessment and follow‐up of acute intermittent porphyria patients

Role of two nutritional hepatic markers (insulin‐like growth factor 1 and transthyretin) in the... Abstract. Objective. Acute intermittent porphyria (AIP) is caused by a deficiency of hydroxymethylbilane synthase. Clinical manifestations are abdominal pain and neurovisceral symptoms, accompanied by overproduction of heme‐precursors in the liver, which frequently remains long‐lasting in AIP patients. We tested the hypothesis that this condition may be associated with alterations of hepatic proteins known to be either increased or decreased in serum according to diverse pathological conditions including malnutrition, inflammation or liver disease. Design. Serum proteins were analyzed in 26 biochemically active AIP patients that were classified according to the EPI (European Porphyria Initiative) guidelines as follows: (i) patients who presented a single acute attack having remained so far free of clinical symptoms; (ii) patients who present recurrent attacks or chronic symptoms associated with exacerbations of AIP. Results. Most of the serum proteins were within normal limits, however insulin‐like growth factor 1 (IGF‐1) was decreased in 53.8% of AIP patients (z‐score = −2.86 ± 0.37) and transthyretin (prealbumin) was found significantly decreased in 38.5% of them. The IGF‐1 z‐score was lower in group B versus group A patients (−2.66 vs. −1.43; P = 0.024). The coincident decrease of both IGF‐1 and transthyretin was associated with worsening of the clinical condition. Conclusions. This first study in humans suggests that the clinical expression AIP is associated with a state of under‐nutrition and/or with hepatic inflammation due to the sustained accumulation of heme‐precursors. We propose the use of both IGF‐1 and transthyretin as biomarkers of disease morbidity/severity for the clinical follow‐up of AIP patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Internal Medicine Wiley

Role of two nutritional hepatic markers (insulin‐like growth factor 1 and transthyretin) in the clinical assessment and follow‐up of acute intermittent porphyria patients

Download PDF
9 pages

Loading next page...
 
/lp/wiley/role-of-two-nutritional-hepatic-markers-insulin-like-growth-factor-1-T0RDEBorii

References (31)

Publisher
Wiley
Copyright
© 2009 Blackwell Publishing Ltd
ISSN
0954-6820
eISSN
1365-2796
DOI
10.1111/j.1365-2796.2009.02118.x
pmid
19570056
Publisher site
See Article on Publisher Site

Abstract

Abstract. Objective. Acute intermittent porphyria (AIP) is caused by a deficiency of hydroxymethylbilane synthase. Clinical manifestations are abdominal pain and neurovisceral symptoms, accompanied by overproduction of heme‐precursors in the liver, which frequently remains long‐lasting in AIP patients. We tested the hypothesis that this condition may be associated with alterations of hepatic proteins known to be either increased or decreased in serum according to diverse pathological conditions including malnutrition, inflammation or liver disease. Design. Serum proteins were analyzed in 26 biochemically active AIP patients that were classified according to the EPI (European Porphyria Initiative) guidelines as follows: (i) patients who presented a single acute attack having remained so far free of clinical symptoms; (ii) patients who present recurrent attacks or chronic symptoms associated with exacerbations of AIP. Results. Most of the serum proteins were within normal limits, however insulin‐like growth factor 1 (IGF‐1) was decreased in 53.8% of AIP patients (z‐score = −2.86 ± 0.37) and transthyretin (prealbumin) was found significantly decreased in 38.5% of them. The IGF‐1 z‐score was lower in group B versus group A patients (−2.66 vs. −1.43; P = 0.024). The coincident decrease of both IGF‐1 and transthyretin was associated with worsening of the clinical condition. Conclusions. This first study in humans suggests that the clinical expression AIP is associated with a state of under‐nutrition and/or with hepatic inflammation due to the sustained accumulation of heme‐precursors. We propose the use of both IGF‐1 and transthyretin as biomarkers of disease morbidity/severity for the clinical follow‐up of AIP patients.

Journal

Journal of Internal Medicine – Wiley

Published: Sep 1, 2009

There are no references for this article.